FDA Inspection
Aucta Pharmaceuticals, Inc.Aucta Pharmaceuticals, Inc. – FDA Inspection, Oct 3, 2025
Record Details
This FDA Inspection record concerns Aucta Pharmaceuticals, Inc., with an inspection on October 3, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 11bf0650-c533-4a0e-aef6-04a560c15fa1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1285696
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aucta Pharmaceuticals, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 16, 2023 | Not classified | New Jersey District Office | |
| June 7, 2023 | Not classified | New Jersey District Office |
Other documents for Aucta Pharmaceuticals, Inc.
- FDA Inspection 1222312 - 2023-10-16
- FDA Inspection 1208383 - 2023-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.